Litcius/Paper detail

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

Lianne Beunk, Marga Nijenhuis, Bianca Soree, Nienke J. de Boer‐Veger, Anne‐Marie Buunk, Henk‐Jan Guchelaar, Elisa J. F. Houwink, Arne Risselada, Gerard A. Rongen, Ron H. N. van Schaik, Jesse J. Swen, Daan J. Touw, Roos van Westrhenen, Vera H.M. Deneer, Jan van der Weide

2023European Journal of Human Genetics150 citationsDOIOpen Access PDF

Topics & Concepts

RisperidoneAripiprazoleQuetiapineOlanzapineCYP2D6PharmacologyMedicineClozapinePharmacogeneticsPimozideHaloperidolPsychiatryInternal medicineGenotypeSchizophrenia (object-oriented programming)BiologyGeneticsDopamineCytochrome P450MetabolismGenePharmacogenetics and Drug MetabolismSchizophrenia research and treatmentPharmaceutical studies and practices
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics | Litcius